Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fidarestat (SNK 860), an aldose reductase inhibitor, exhibits IC50 values of 26 nM, 33 μM, and 1.8 μM against aldose reductase, AKR1B10, and V301L AKR1B10 respectively, demonstrating potential for diabetes treatment.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $50 | In Stock | |
5 mg | $249 | In Stock | |
10 mg | $399 | In Stock | |
25 mg | $463 | In Stock | |
1 mL x 10 mM (in DMSO) | $199 | In Stock |
Description | Fidarestat (SNK 860), an aldose reductase inhibitor, exhibits IC50 values of 26 nM, 33 μM, and 1.8 μM against aldose reductase, AKR1B10, and V301L AKR1B10 respectively, demonstrating potential for diabetes treatment. |
Targets&IC50 | AKR1B10 (V301L):1.8 μM, Aldose reductase:26 nM, AKR1B10:33 μM |
In vivo | Fidarestat (1 or 4 mg/kg, orally, daily, for 4 weeks) treatment of diabetic rats reduced sorbitol and fructose concentrations in diabetic rats.[1] |
Synonyms | SNK860, SNK 860 |
Molecular Weight | 279.22 |
Formula | C12H10FN3O4 |
Cas No. | 136087-85-9 |
Smiles | O=C1[C@]2(C=3C(O[C@H](C(N)=O)C2)=CC=C(F)C3)NC(=O)N1 |
Relative Density. | 1.61 g/cm3 (Predicted) |
Color | White |
Appearance | Solid |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (358.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.